Back
Rollins, Inc. 10K Form
Buy
55
ROL
Rollins, Inc.
Last Price:
$60.89
Seasonality Move:
0.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | ROL/Rollins, Inc. Quarterly |
| 2023-10-26 | 10Q | ROL/Rollins, Inc. Quarterly |
| 2023-07-27 | 10Q | ROL/Rollins, Inc. Quarterly |
| 2023-04-27 | 10Q | ROL/Rollins, Inc. Quarterly |
| 2022-10-27 | 10Q | ROL/Rollins, Inc. Quarterly |
| 2022-07-28 | 10Q | ROL/Rollins, Inc. Quarterly |
Receive ROL News And Ratings
See the #1 stock for the next 7 days that we like better than ROL
ROL Financial Statistics
Sales & Book Value
| Annual Sales: | $3.8B |
|---|---|
| Cash Flow: | $159M |
| Price / Cash Flow: | 45.35 |
| Annual Sales: | $2.86 |
| Price / Book: | 21.32 |
Profitability
| EPS (TTM): | 1.08780 |
|---|---|
| Net Income (TTM): | $526.7M |
| Gross Margin: | $1.9B |
| Return on Equity: | 37.43% |
| Return on Assets: | 17.2% |
Rollins, Inc. Earnings Forecast
Key Rollins, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for ROL is 49.44%.
-
The Selling, General & Administrative Expenses for ROL have been equal to 30.13% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 5.42% of Operating Income.
-
The Net Earning history of ROL is 14.00% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 29 years.
Rollins, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | ROL |
| CUSIP: | 775711 |
| Website: | rollins.com |
Debt
| Debt-to-Equity Ratio: | 0.76 |
|---|---|
| Current Ratio: | 0.58 |
| Quick Ratio: | 0.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 55.97 |
|---|---|
| Forward P/E Ratio: | 43.26 |
ROL Technical Analysis vs Fundamental Analysis
Buy
55
Rollins, Inc. (ROL)
is a Buy
Is Rollins, Inc. a Buy or a Sell?
-
Rollins, Inc. stock is rated a BuyThe current Rollins, Inc. [ROL] share price is $60.89. The Score for ROL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.